200
Participants
Start Date
June 14, 2012
Primary Completion Date
September 23, 2016
Study Completion Date
September 23, 2016
Dolutegravir
Eligible patients will receive DTG 50 mg given orally BID
GSK Investigational Site, Brussels
GSK Investigational Site, The Bronx
GSK Investigational Site, Antwerp
GSK Investigational Site, Porto Alegre
GSK Investigational Site, Liège
GSK Investigational Site, New York
GSK Investigational Site, Marseille
GSK Investigational Site, Genoa
GSK Investigational Site, Genoa
GSK Investigational Site, Lancaster
GSK Investigational Site, Philadelphia
GSK Investigational Site, Milan
GSK Investigational Site, Lübeck
GSK Investigational Site, Pavia
GSK Investigational Site, Venezia
GSK Investigational Site, Atlanta
GSK Investigational Site, Orlando
GSK Investigational Site, Vero Beach
GSK Investigational Site, Bordeaux
GSK Investigational Site, Fort Lauderdale
GSK Investigational Site, Fort Lauderdale
GSK Investigational Site, St. Petersburg
GSK Investigational Site, Modena
GSK Investigational Site, Osnabrück
GSK Investigational Site, Bagno A Ripoli (FI)
GSK Investigational Site, Florence
GSK Investigational Site, Cologne
GSK Investigational Site, Bonn
GSK Investigational Site, Frankfurt am Main
GSK Investigational Site, Chicago
GSK Investigational Site, Chicago
GSK Investigational Site, Chicago
GSK Investigational Site, St Louis
GSK Investigational Site, Topeka
GSK Investigational Site, Mannheim
GSK Investigational Site, Omaha
GSK Investigational Site, Stuttgart
GSK Investigational Site, Paris
GSK Investigational Site, Paris
GSK Investigational Site, Paris
GSK Investigational Site, Dallas
GSK Investigational Site, Paris
GSK Investigational Site, Paris
GSK Investigational Site, Paris
GSK Investigational Site, Paris
GSK Investigational Site, Houston
GSK Investigational Site, Houston
GSK Investigational Site, Austin
GSK Investigational Site, Freiburg im Breisgau
GSK Investigational Site, Denver
GSK Investigational Site, Phoenix
GSK Investigational Site, San Francisco
GSK Investigational Site, Le Kremlin-Bicêtre
GSK Investigational Site, Chapel Hill
GSK Investigational Site, Graz
GSK Investigational Site, Linz
GSK Investigational Site, Vienna
GSK Investigational Site, Ipanema
GSK Investigational Site, Macaé
GSK Investigational Site, São Paulo
GSK Investigational Site, Fortaleza
GSK Investigational Site, Maceió
GSK Investigational Site, Ribeirão Preto
GSK Investigational Site, Rio de Janeiro
GSK Investigational Site, Rio de Janeiro
GSK Investigational Site, Rio de Janeiro
GSK Investigational Site, São Paulo
GSK Investigational Site, Vittoria
GSK Investigational Site, Vancouver
GSK Investigational Site, Hamilton
GSK Investigational Site, Toronto
GSK Investigational Site, Montreal
GSK Investigational Site, Nice
GSK Investigational Site, Szczecin
Lead Sponsor
Collaborators (1)
GlaxoSmithKline
INDUSTRY
ViiV Healthcare
INDUSTRY